STAT18d
Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency
Patrizia Cavazzoni, leader of the Food and Drug Administration’s Center for Drug Evaluation and Research, is leaving the agency on Jan. 18, the latest top official to exit as Donald Trump ...
FiercePharma18d
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire from the agency. The seven-year FDA veteran communicated the decision in ...
Hosted on MSN17d
FDA CDER director Patrizia Cavazzoni announces resignation
The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research (CDER), Patrizia Cavazzoni, has announced her resignation ahead of Donald ...
Investor's Business Daily on MSN11d
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...
Business Insider3y
The FDA has authorized pills to treat COVID-19, replenishing the tool kit of treatments against Omicron
while continuing to generate additional data on their safety and effectiveness," Dr. Patrizia Cavazzoni, the director of the FDA's Center for Drug Evaluation and Research, said in a statement on ...
Benzinga.com18d
Patrizia Cavazzoni, head of FDA's drug center, to leave the agency
Patrizia Cavazzoni, leader of the Food and Drug Administration’s Center for Drug Evaluation and Research, is leaving the agency on Jan. 18. The director shared the news with staff on Friday ...
Pharmaceutical Technology18d
FDA CDER director Patrizia Cavazzoni announces resignation
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January. Merging industry-leading business intelligence & award-winning journalism, this is an ...